Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02425228 · ClinicalTrials.gov registry record
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 300
- Enrollment target
NCT02425228: Completed study, sponsored by Jonsson Comprehensive Cancer Center.
NCT02425228 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02425228 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer. This is a diagnostic trial using each patient as his own control.
Primary Outcome
Patient participation is only confined to the biopsy visit.
Interventions
- DEVICE Targeted biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-12-04 |
| Est. Completion | 2018-12-18 |
What the finished NCT02425228 record still lists
NCT02425228 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Targeted biopsy is the first listed.
NCT02425228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02425228 about?
NCT02425228 is a clinical study titled "Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer". This is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer. This is a diagnostic trial using each patient as his own control.
What is the current status of trial NCT02425228?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2014-12-04. Estimated completion is 2018-12-18.
What interventions are being tested in trial NCT02425228?
The interventions under investigation include: Targeted biopsy (DEVICE).
Who is sponsoring clinical trial NCT02425228?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI